0001237899-12-000060.txt : 20120620 0001237899-12-000060.hdr.sgml : 20120620 20120620111248 ACCESSION NUMBER: 0001237899-12-000060 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120618 FILED AS OF DATE: 20120620 DATE AS OF CHANGE: 20120620 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STAHL NEIL CENTRAL INDEX KEY: 0001226689 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 12916719 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 4 1 edgardoc.xml PRIMARY DOCUMENT X0305 4 2012-06-18 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001226689 STAHL NEIL 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 SVP Res & Dev Sciences Common Stock 2012-06-18 4 M 0 95079.0 20.32 A 154200.0 D Common Stock 2012-06-18 4 F 0 16757.0 115.29 D 137443.0 D Common Stock 2012-06-18 4 F 0 39411.0 115.29 D 98032.0 D Common Stock 2012-06-19 4 S 0 24848.0 115.6 D 73184.0 D Common Stock 2012-06-19 4 S 0 9080.0 116.41 D 64104.0 D Common Stock 2012-06-19 4 S 0 4383.0 117.34 D 59721.0 D Common Stock 2012-06-19 4 S 0 600.0 118.1 D 59121.0 D Common Stock 5479.0 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 20.32 2012-06-18 4 M 0 95079.0 D 2016-12-18 Common Stock 95079.0 0.0 D Non-Qualified Stock Option (right to buy) 115.29 2012-06-18 4 A 0 16757.0 0.0 A 2012-12-18 2016-12-18 Common Stock 16757.0 16757.0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 24,848 shares of Company stock on June 19, 2012 at prices ranging from $115.23 to $115.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 19, 2012 at each separate price. Represents volume-weighted average price of sales of 9,080 shares of Company stock on June 19, 2012 at prices ranging from $116.01 to $116.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 19, 2012 at each separate price. Represents volume-weighted average price of sales of 4,383 shares of Company stock on June 19, 2012 at prices ranging from $117.00 to $117.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 19, 2012 at each separate price. Represents volume-weighted average price of sales of 600 shares of Company stock on June 19, 2012 at prices ranging from $118.00 to $118.19. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 19, 2012 at each separate price. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case. /s/**Neil Stahl 2012-06-20